Cellular mechanisms of liver fibrosis

P Acharya, K Chouhan, S Weiskirchen… - Frontiers in …, 2021 - frontiersin.org
The liver is a central organ in the human body, coordinating several key metabolic roles. The
structure of the liver which consists of the distinctive arrangement of hepatocytes, hepatic …

[HTML][HTML] Primary sclerosing cholangitis–a comprehensive review

TH Karlsen, T Folseraas, D Thorburn, M Vesterhus - Journal of hepatology, 2017 - Elsevier
Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct
strictures and progressive liver disease. Inflammatory bowel disease is usually present and …

[PDF][PDF] Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

K Boonstra, RK Weersma, KJ van Erpecum… - …, 2013 - Wiley Online Library
Extensive population‐based studies are much needed to accurately establish epidemiology
and disease course in patients with primary sclerosing cholangitis (PSC). We aimed to …

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver …

L Aabakken, TH Karlsen, J Albert, M Arvanitakis… - …, 2017 - thieme-connect.com
1 ESGE/EASL recommend that, as the primary diagnostic modality for PSC, magnetic
resonance cholangiography (MRC) should be preferred over endoscopic retrograde …

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

M Rutter, B Saunders, K Wilkinson, S Rumbles… - Gastroenterology, 2004 - Elsevier
Background & Aims: Patients with ulcerative colitis are at increased risk of colorectal cancer.
It is widely believed that this is secondary to colonic inflammation. However, the severity of …

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

EV Loftus, GC Harewood, CG Loftus, WJ Tremaine… - Gut, 2005 - gut.bmj.com
Background: Inflammatory bowel disease associated with primary sclerosing cholangitis
(PSC-IBD) may have a high prevalence of rectal sparing, backwash ileitis, and colorectal …

Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis

C Castaño‐Milla, M Chaparro… - Alimentary …, 2014 - Wiley Online Library
Background Patients with ulcerative colitis (UC) have an increased risk of developing
colorectal cancer (CRC); however, the magnitude of this effect is open to debate. Aim To …

Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis

MD Rutter, BP Saunders, KH Wilkinson, S Rumbles… - Gastroenterology, 2006 - Elsevier
Background & Aims: The value of colonoscopic surveillance for neoplasia in long-standing
extensive ulcerative colitis remains controversial. This study reports on prospectively …

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

RM Soetikno, OS Lin, PA Heidenreich… - Gastrointestinal …, 2002 - Elsevier
Background: Published data on the risk of colorectal neoplasia in patients with ulcerative
colitis with and without primary sclerosing cholangitis are conflicting. A meta-analysis was …

[HTML][HTML] Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies

PL Lakatos, L Lakatos - World journal of gastroenterology: WJG, 2008 - ncbi.nlm.nih.gov
The risk of colorectal cancer for any patient with ulcerative colitis is known to be elevated,
and is estimated to be 2% after 10 years, 8% after 20 years and 18% after 30 years of …